Advances in the Treatment of Alzheimer Disease: Current Landscape and Future Directions

home / peer-exchange / advances-in-the-treatment-of-alzheimer-disease-current-landscape-and-future-directions

A panel of experts on Alzheimer disease discuss the evolving treatment landscape, focusing on cost considerations and the disease’s impact on patients, families, and caregivers.

Episodes

A panel of 5 experts on Alzheimer disease

May 15th 2024EP. 1: The Clinical and Economic Implications of Alzheimer Disease Across Patients, Families, and the Health Care System

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

A panel of experts on Alzheimer disease provide insights on symptoms the patient might experience and the impact of the disease on patients, families, caregivers, and the health care system.

B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS

May 15th 2024EP. 2: Recent Insights into the Pathophysiology of Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

B. Joy Snider, MD, PhD, gives an overview of the pathophysiology of Alzheimer disease, highlighting recent advances in the field.

May 22nd 2024EP. 3: Genetic Aspects of Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

The panel provides an overview of genetic factors associated with Alzheimer disease and the genetic mutations that contribute to the pathophysiology of the disease.

May 22nd 2024EP. 4: The Patient Experience: From Symptoms to Diagnosis of Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

The expert panel offers comprehensive insights on the patient journey for people with Alzheimer disease, highlighting symptoms, challenges, and the diagnostic process.

Video 5 - "Potential Consequences of Early Diagnosis of Alzheimer Disease"

May 29th 2024EP. 5: Potential Consequences of Early Diagnosis of Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

B. Joy Snider, MD, PhD, discusses the benefits of early diagnosis of Alzheimer disease and how it can impact the patient journey.

May 29th 2024EP. 6: Criteria for Diagnosing Alzheimer Disease and the Role of Testing

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

Focusing on the diagnosis of Alzheimer disease, the panel discusses key diagnostic criteria, testing practices, and the role of genetic testing.

A panel of experts on Alzheimer's disease

June 5th 2024EP. 7: Exploring the Economic Impact of Advanced Approaches for Diagnosing Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

The panel provides insights on the economic impact of advanced approaches for diagnosing Alzheimer disease, highlighting how payers approach increased costs.

June 5th 2024EP. 8: Clinical Impact of the Introduction of Disease-Modifying Treatments for Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

Experts on Alzheimer disease discuss how the introduction of disease-modifying therapies has impacted the treatment landscape.

June 12th 2024EP. 9: Clinical Decision-Making for Alzheimer Disease Management

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

Experts provide their perspectives on clinical factors taken into consideration when deciding on a treatment plan for a patient with Alzheimer disease.

June 12th 2024EP. 10: Cost, Value, and Affordability of Treatment for Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

A comprehensive discussion on the value of therapies for Alzheimer disease based on cost vs outcome, and unmet needs in the overall treatment landscape.

June 19th 2024EP. 11: Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.

June 19th 2024EP. 12: Exploring the Influence of Administration Routes on Medical Costs and Caregiver Burden

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

An overview of how disease-modifying treatments for Alzheimer disease can impact medical costs and caregiver burden.

June 26th 2024EP. 13: Payer Coverage Considerations for New Treatments for Alzheimer Disease

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

Experts discuss how payers can prepare for new treatments and plan adequate coverage for patients with Alzheimer disease.

June 26th 2024EP. 14: Concluding Remarks: Impact of Alzheimer Disease, Promising Treatments in Development, and Future Outlook

Derek van Amerongen, MD, MS;Soeren Mattke, MD, DSc;B. Joy Snider, MD, PhD;Kavita V. Nair, PhD;Maria Lopes, MD, MS

Looking to the future of Alzheimer disease treatment, the panel discusses key takeaways on the evolving therapeutic landscape.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions